Kelliann C. Fee-Schroeder

12 papers receiving 252 citations

Peers

Kelliann C. Fee-Schroeder
Comparison fields: 5 of 68
  • Oncology 158
  • Pediatrics, Perinatology and Child Health 65
  • Public Health, Environmental and Occupational Health 52
  • Physiology 49
  • Pulmonary and Respiratory Medicine 46
Replace Maxwell T. Vergo with:
Maxwell T. Vergo United States
Choi Wan Chan Hong Kong
Kirsty Rickett Australia
Jacqueline S. Drouin United States
Lisa Massie United States
Sara Mella Italy
Dawn Lemanne United States
Benedetta Ruggeri Italy
Paul H. Kloeg Netherlands
Evelien Kuip Netherlands
Kelliann C. Fee-Schroeder relative to Maxwell T. Vergo United States Maxwell T. Vergo's profile →
Citations per field
00.5×1.5×2.2×
Maxwell T. Vergo · 1×
Citations per year

Countries citing papers authored by Kelliann C. Fee-Schroeder

Since Specialization
Citations

This map shows the geographic impact of Kelliann C. Fee-Schroeder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelliann C. Fee-Schroeder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelliann C. Fee-Schroeder more than expected).

Fields of papers citing papers by Kelliann C. Fee-Schroeder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelliann C. Fee-Schroeder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelliann C. Fee-Schroeder. The network helps show where Kelliann C. Fee-Schroeder may publish in the future.

Co-authorship network of co-authors of Kelliann C. Fee-Schroeder

This figure shows the co-authorship network connecting the top 25 collaborators of Kelliann C. Fee-Schroeder. A scholar is included among the top collaborators of Kelliann C. Fee-Schroeder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelliann C. Fee-Schroeder. Kelliann C. Fee-Schroeder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
#WorkIndexed citations
1 0
2 23
3 5
4 4
5 67
6 5
7 12
8 10
9 5
10 101
11 6
12 7
13 13

About Kelliann C. Fee-Schroeder

Kelliann C. Fee-Schroeder is a scholar working on Pharmacology, Dermatology and Oncology, having authored 13 papers that have together received 258 indexed citations. Recurring topics across this work include Nausea and vomiting management (3 papers), Cancer survivorship and care (3 papers) and Cancer Treatment and Pharmacology (3 papers). The work is most often cited by research in Oncology (158 citations), Dermatology (32 citations) and Pediatrics, Perinatology and Child Health (65 citations). Kelliann C. Fee-Schroeder has collaborated with scholars based in United States. Frequent co-authors include Debra L. Barton, Paul J. Novotny, Daniel Satele, Charles L. Loprinzi, Drew K. Seisler, Deirdre R. Pachman, Thomas J. Smith, Daniel H. Lachance, Heshan Liu and Andrea Cheville. Their work appears in journals such as Journal of Clinical Oncology, Supportive Care in Cancer and Oncology nursing forum.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026